Atorvastatin, a new HMG-CoA reductase inhibitor (HMGRI), is...

Atherosclerosis 1994 / 9 Vol. 109; Iss. 1-2

Atorvastatin, a new HMG-CoA reductase inhibitor (HMGRI), is safe and effective in hypertriglyceridemic patients

Bakker-Arkema, R., Davidson, M., Goldstein, R., Davignon, J., Isaacsohn, J., Weiss, S., Keilson, L., Brown, V., Miller, V., Shurzinske, L., Black, D.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
109
Language:
english
Journal:
Atherosclerosis
DOI:
10.1016/0021-9150(94)94256-0
Date:
September, 1994
File:
PDF, 157 KB
english, 1994
Conversion to is in progress
Conversion to is failed